Results 41 to 50 of about 129,762 (268)
Assembly 12: interstitial lung diseases [PDF]
Breathe, 2018 Meet @ERStalk Assembly 12: interstitial lung diseases http://ow.ly/Bp0730m9zX4.
Antoniou, Katerina +3 more
openaire +3 more sources
Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis
Medical Sciences, 2018 Idiopathic pulmonary fibrosis (IPF), a devastating progressive interstitial lung disease (ILD) with no known cause, is the most common and deadly of the idiopathic interstitial pneumonias.
Estrella Fernández Fabrellas +3 more
doaj +1 more source
Small airway dysfunction in pneumoconiosis: a cross-sectional study
BMC Pulmonary Medicine, 2022 Background Although several histological studies have documented airway inflammation and remodelling in the small airways of dust-exposed workers, little is known regarding the prevalence and risk factors of small airway dysfunction (SAD) in ...
Yali Fan +5 more
doaj +1 more source
Is the internet a sufficient source of information on sarcoidosis?
Frontiers in Medicine, 2023 IntroductionMany patients use the internet as a source of health information. Sarcoidosis is a complex disease, and internet resources have not yet been analyzed for reliability and content on sarcoidosis.AimsOur study aimed to investigate the content ...
Katharina Buschulte +11 more
doaj +1 more source
Cells, 2021 Mechanistic target of rapamycin complex 1 (mTORC1) has been linked to different diseases. The mTORC1 signaling pathway is suggested to play a role in the granuloma formation of sarcoidosis.
Raisa Kraaijvanger +7 more
doaj +1 more source
Familial Interstitial Lung Disease
Seminars in Respiratory and Critical Care Medicine, 2020 AbstractThe interstitial lung diseases (ILDs) are a group of progressive disorders characterized by chronic inflammation and/or fibrosis in the lung. While some ILDs can be linked to specific environmental causes (i.e., asbestosis, silicosis), in many individuals, no culprit exposure can be identified; these patients are deemed to have “idiopathic ...
openaire +3 more sources
The therapy of idiopathic pulmonary fibrosis: what is next?
European Respiratory Review, 2019 Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung disease, characterised by progressive scarring of the lung and associated with a high burden of disease and early death.
Vivien Somogyi +5 more
doaj +1 more source
BMC Pulmonary Medicine, 2017 Background Asbestosis and silicosis are progressive pneumoconioses characterized by interstitial fibrosis following exposure to asbestos or silica dust. We evaluated the potential diagnostic biomarkers for these diseases. Methods The serum concentrations
Changjiang Xue +5 more
doaj +1 more source
Arthritis Care &Research, EarlyView.We report the national burden of dermatopolymyositis mortality over the past quarter century using the US national vital statistics data. Age‐standardized mortality rates for dermatopolymyositis decreased at an annual rate of 3.8% each year, which was higher than the annual percent decrease for deaths from all other causes.
Elizabeth Matz, Ram R. Singh
wiley +1 more source
Arthritis Care &Research, EarlyView.Objective In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently, and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of the trajectory of a ...
Ji Soo Kim +18 more
wiley +1 more source